Dr. Neumayr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
747 52nd St
Oakland, CA 94609Phone+1 510-428-3885Fax+1 510-428-3840
Education & Training
Children's Hospital-OaklandResidency, Pediatrics, 1986 - 1990
University of California San Diego School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1987 - 2025- American Board of Pediatrics Pediatrics
Clinical Trials
- Dose-Finding Study of SC411 in Children With Sickle Cell Disease Start of enrollment: 2017 Mar 02
Publications & Presentations
PubMed
- 8 citationsEngaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial.Anna M Hood, Heather Strong, Cara Nwankwo, Yolanda Johnson, James Peugh
JMIR Research Protocols. 2021-05-21 - 25 citationsOsteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management.Oyebimpe O. Adesina, Lynne Neumayr
Hematology. American Society of Hematology. Education Program. 2019-12-06 - 19 citationsSickle cell disease: current treatment and emerging therapies.Lynne Neumayr, Carolyn Hoppe, Clark Brown
The American Journal of Managed Care. 2019-11-01
Journal Articles
- A Phase 3 Trial of L-glutamine in Sickle Cell DiseaseRita Bellevue, Joseph L Lasky, Elliott P Vichinsky, Lewis L Hsu, Sharada Sarnaik, Lynne D Neumayr, Yutaka Niihara, Sophie Lanzkron, Ifeyinwa Osunkwo, Lance Sieger, Edu..., The New England Journal of Medicine
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
